Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
MMP-9 deficiency confers resilience in Fibrodysplasia Ossificans Progressiva in a man and mice.
Alteration in the gut microbiome is associated with changes in bone metabolism after laparoscopic sleeve gastrectomy.
Bone marrow adiposity alterations in type 2 diabetes are sex-specific and associated with serum lipid levels.
Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review.
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1R206H -Specific Human Cellular and Zebrafish Models.
Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.
The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
